Shh, Recombinant, Human (Sonic HedgeHog)

Catalog No : USB-S1012-96
580.48€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Shh, Recombinant, Human (Sonic HedgeHog)
Catalog No USB-S1012-96
Supplier’s Catalog No S1012-96
Supplier US Biologicals
Source antigen Recombinant, Human expressed in E. coli
Reactivity
Cross reactivity
Applications
Molecular weight
Storage -20°C
Other names
Grade Highly Purified
Purity ~97% by SDS-PAGE, silver stain Endotoxin: ≤EU/ug
Form Supplied as a lyophilized powder from PBS, BSA. Reconstitute with sterile PBS, ≥ 0.1% HSA or BSA to make a final concentration of ≥ 50ug/ml.
Reactivity life 6 months
Note For reserch purpose only
Purity ~97% by SDS-PAGE, silver stain Endotoxin: ≤EU/ug
Description Members of the Hedgehog (Hh) family are highly conserved proteins which are widely represented throughout the animal kingdom. The three known mammalian Hh proteins, Sonic (Shh), Desert (Dhh) and Indian (Ihh) are structurally related and share a high degree of amino-acid sequence identity (e.g., Shh and Ihh are 93% identical). The biologically active form of Hh molecules is obtained by autocatalytic cleavage of their precursor proteins and corresponds to approximately the N-terminal one half of the precursor molecule. Although Hh proteins have unique expression patterns and distinct biological roles within their respective regions of secretion, they use the same signaling pathway and can substitute for each other in experimental systems. Sonic Hedgehog, which is expressed only during embryogenesis, is instrumental in patterning the early embryo. It has been implicated as the key inductive signal in patterning of the ventral neural tube, the anterior-posterior limb axis, and the ventral somites. Of three human proteins showing sequence and functional similarity to the Sonic Hedgehog protein of Drosophila, this protein is the most similar. The protein is made as a precursor that is autocatalytically cleaved; the N-terminal portion is soluble and contains the signalling activity while the C-terminal portion is involved in precursor processing. More importantly, the C-terminal product covalently attaches a cholesterol moiety to the N-terminal product, restricting the N-terminal product to the cell surface and preventing it from freely diffusing throughout the developing embryo. Defects in this protein or in its signalling pathway are a cause of holoprosencephaly (HPE), a disorder in which the developing forebrain fails to correctly separate into right and left hemispheres. HPE is manifested by facial deformities. In addition, it is thought that mutations in this gene or in its signalling pathway may be responsible for VACTERL syndrome, which is characterized by vertebral defects, anal atresia, tracheoesophageal fistula with esophageal atresia, radial and renal dysplasia, cardiac anomalies, and limb abnormalities. A DNA sequence encoding amino acid residues Cys 24–Gly 197 of human SHH (Accession number NP_000184; Riddle, R.D. et al., 1993, Cell 75:1401–1416) was fused to a 6X histidine tag at the carboxy-terminus. The fusion protein was expressed in E. coli. Molecular Mass: The 180 amino acid residue recombinant human Shh-N has a predicted molecular mass of approximately 20kD. Activity: Measured by its ability to induce alkaline phosphatase production by C3H10T1/2 fibroblasts (Nakamura, T. et al., 1997, Biochem. Biophys. Res. Commun. 237:465). The ED50 for this effect is typically 2-8ug/ml. Storage and Stability: Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile PBS, ≥ 0.1% HSA or BSA. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.